Journal
JOURNAL OF BIOMEDICAL SCIENCE
Volume 21, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1423-0127-21-16
Keywords
Hand foot and mouth disease; Enterovirus epidemiology; Seroprevalence; Human enterovirus 71
Categories
Funding
- Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University
- National Research Council of Thailand
- Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission [HR1155A]
- Centenary Academic Development Project
- Integrated Innovation Academic Center
- Chulalongkorn University Centenary Academic Development Project [CU56-HR01]
- Outstanding Professor of the Thailand Research Fund [DPG5480002]
- Presidents' Forum of Southeast and South Asia and Taiwan University (SATU)
- Center of Infectious Disease and Signaling Research, National Cheng Kung University, Aim for the Top University Project, Ministry of Education, Taiwan
- Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0087/2554]
Ask authors/readers for more resources
Background: Human enterovirus 71 (EV71) is an important pathogen caused large outbreaks in Asian-Pacific region with severe neurological complications and may lead to death in young children. Understanding of the etiological spectrum and epidemic changes of enterovirus and population's immunity against EV71 are crucial for the implementation of future therapeutic and prophylactic intervention. Results: A total of 1,182 patients who presented with the symptoms of hand foot and mouth disease (67.3%) or herpangina (HA) (16.7%) and admitted to the hospitals during 2008-2013 were tested for enterovirus using pan-enterovirus PCR targeting 5'-untranslated region and specific PCR for viral capsid protein 1 gene. Overall, 59.7% were pan-enterovirus positive comprising 9.1% EV71 and 31.2% coxsackievirus species A (CV-A) including 70.5% CV-A6, 27.6% CV-A16, 1.1% CV-A10, and 0.8% CV-A5. HFMD and HA occurred endemically during 2008-2011. The number of cases increased dramatically in June 2012 with the percentage of the recently emerged CV-A6 significantly rose to 28.4%. Co-circulation between different EV71 genotypes was observed during the outbreak. Total of 161 sera obtained from healthy individuals were tested for neutralizing antibodies (NAb) against EV71 subgenotype B5 (EV71-B5) using microneutralization assay. The seropositive rate of EV71-B5 was 65.8%. The age-adjusted seroprevalence for individuals was found to be lowest in children aged >6 months to 2 years (42.5%). The seropositive rate remained relatively low in preschool children aged > 2 years to 6 years (48.3%) and thereafter increased sharply to more than 80% in individuals aged > 6 years. Conclusions: This study describes longitudinal data reflecting changing patterns of enterovirus prevalence over 6 years and demonstrates high seroprevalences of EV71-B5 NAb among Thai individuals. The rate of EV71 seropositive increased with age but without gender-specific significant difference. We identified that relative lower EV71 seropositive rate in early 2012 may demonstrate widely presented of EV71-B5 in the population before account for a large outbreak scale epidemic occurred in 2012 with due to a relatively high susceptibility of the younger population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available